Eightcap (Cyprus) logo

Eightcap (Cyprus)

Cyprus-regulated CFD broker offering 800+ markets with TradingView, MT4/MT5, and AI-powered trading tools

InvestingAvailable in EnglishMiFID II passported
3.5/ 5
Compare with...

Get notified when Eightcap (Cyprus) updates fees, status, or features.

Email alerts coming soon. We will email you when there is something worth telling you about.

Founded:2009
HQ:Cyprus
Regulator:CySEC

Rating breakdown

Overall
3.5
Fees
3.5
Platform
4.0
Safety
3.0
Product range
3.5

Pros

  • 800+ CFD markets with tight spreads
  • TradingView integration for charting
  • MT4 and MT5 platforms available
  • AI-powered economic calendar and trade ideas
  • Trustpilot 4.1/5 rating

Cons

  • 83.36% of retail CFD accounts lose money
  • CFD-only — no real stock ownership
  • High leverage risk
  • Pricing page not detailed

Fees & costs

Standard + Raw account options

Fee typeCost
Stock tradingSpread-based (CFDs only)

Fees as of 23 March 2026. Always verify on the platform's website.

Available products

Stocks
ETFs
Bonds
Options
Futures
Crypto
CFDs
Forex
Funds

Platform & features

Available on

Web platform
Mobile app
Desktop app
API access

Key features

Fractional shares
Savings plan
Demo account
Copy trading

Availability

Languages

English

Available in 12 countries

🇨🇾Cyprus🇭🇷Croatia🇧🇬Bulgaria🇳🇱Netherlands🇩🇪Germany🇫🇷France🇦🇹Austria🇪🇸Spain🇮🇹Italy🇮🇪Ireland🇵🇱Poland🇬🇧United Kingdom

Similar platforms

Related guides

Recommended reading

Your shortlist

Community

Share your experience

Help other Europeans choose by writing a short, honest review.

Reviews

What other users say

No reviews yet for Eightcap (Cyprus)

Be the first to share your experience.

Write a review

Investing involves risk. You could lose some or all of your money. Capmap provides educational information only, not financial advice. Always do your own research before investing.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.

Last verified: 23 March 2026. Data confidence: high. Full risk disclaimer